Companies›Commodities›Chemicals›Chemicals & Petrochemicals
NSE:CHEMCRUX

CHEMCRUX ENTERPRISES LTD.

Chemicals › Chemicals & Petrochemicals
₹80.96
at close · 28 Oct 2026
▲ 0.97 (+1.21%)

Latest filings

Next results: Mon, 2 Nov · Financial Results
  1. Board to review Q2 and H1 FY2026-27 results on 2 November · Results
  2. Reg 74(5) Depository Certificate Filed For Sep 2026 Quarter · Compliance
  3. Trading Window Closure from 1 October 2026 · Compliance
All filings ↓
Ask Nexa about CHEMCRUX ENTERPRISES LTD.

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Manufactures specialty chemicals from India, with operating activity concentrated through wholly-owned subsidiary Kalichem Private Limited, which runs a manufacturing facility in Vadodara, Gujarat. Kalichem commenced commercial production in November 2024 and became a wholly-owned subsidiary in February 2025. In May 2026, Kalichem filed a Consent to Establish amendment with the Gujarat Pollution Control Board to add various inorganic chemicals to the Vadodara plant as part of a diversification into the inorganic chemicals sector. The parent has also incorporated a non-profit Section 8 subsidiary, Chemcrux Foundation, to handle CSR activities. In FY26, standalone revenue from operations was Rs 8,257.92 lakh (up 17.5% YoY from Rs 7,025.39 lakh), with standalone profit after tax of Rs 544.97 lakh (up 30.1% YoY). Consolidated FY26 revenue was Rs 8,064.64 lakh with consolidated PAT of Rs 373.08 lakh, lower than standalone because of losses at the Kalichem subsidiary. The Board recommended a 10% dividend (Rs 1 per equity share of Rs 10 face value), subject to shareholder approval. Raw materials are the largest cost line at 35.1% of revenue (Rs 28.33 crore), followed by other operating expenses at 33.9% (Rs 27.34 crore) and employee costs at 11.9% (Rs 9.63 crore). Depreciation was 5.9% of revenue and capex for the year was Rs 5.15 crore.

Operating scale
Manufacturing facility
Vadodara, Gujarat (via subsidiary Kalichem Private Limited)FY26
Subsidiary commercial production start
November 2024 (Kalichem Private Limited)FY26
Diversification pipeline
Application filed with GPCB to add various inorganic chemicals at the Vadodara plantMay 2026
Outstanding borrowings
Rs. 17.88 croreAs of March 31, 2026
ESOP options granted
107,700 stock options at Rs. 10 per option under ESOP 2025FY26
Dividend declared
Rs. 1 per equity share (10% on Rs. 10 face value), subject to AGM approvalFY26
Who pays it
Not specified in the available facts.
Biggest cost
Raw materials at Rs 28.33 crore, or 35.1% of revenue (FY26).
Kind of business
Small-cap specialty chemicals manufacturer with a recently commissioned subsidiary plant and an early-stage push into inorganic chemicals.
Where it sits
A sub-100 crore revenue specialty chemicals company listed on BSE, with consolidated operations running primarily through the Kalichem Private Limited subsidiary in Vadodara.
Market Cap
₹120 Cr
P / E (TTM)
32.3×
EV / EBITDA
11.5×
Div Yield
1.24%
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
8.2%·
ROCE (FY26)
ROE 4.9% · margin 16.3%
Leverage
0.44·
Debt / Equity · low
Net debt ₹31 Cr
Revenue FY24→FY26
1.0×▲
Margin −6.1 pts
₹78 Cr → ₹81 Cr
Cash conversion
2.36×▲
Operating cash ÷ profit · 3 yrs
₹38 Cr on ₹16 Cr
Where it sits among 107 Specialty Chemicals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#66/99
P/B#27/99
ROCE#74/106
ROE#71/99
Debt / Equity#76/99
EBITDA margin#39/99
Revenue growth#15/94
Profit growth#6/92

Scorecard

Measured from the filed financials, judged against its Specialty Chemicals peers · as of FY26 — not investment advice

Strengths
Over 3 years it reported ₹16 Cr of profit and ₹38 Cr of operating cash — 2.36×
Profit is converting into cash
Pays out 40% of profit as dividend
Concerns
Carries more debt than its peers — 0.44× equity
higher than 76% of its 99 Specialty Chemicals peers

Charts

How has the market priced it — with filings on the timeline?

CHEMCRUX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from CHEMCRUX ENTERPRISES LTD.'s filed financials and exchange disclosures

What does CHEMCRUX ENTERPRISES LTD. do?

CHEMCRUX ENTERPRISES LTD. is a Chemicals & Petrochemicals company listed on NSE and BSE, trading under the symbol CHEMCRUX.

Is CHEMCRUX ENTERPRISES LTD. profitable?

Yes. Over the trailing twelve months CHEMCRUX ENTERPRISES LTD. reported a net profit of ₹3.73 Cr on revenue of ₹81 Cr.

Does CHEMCRUX ENTERPRISES LTD. pay a dividend?

Yes. The dividend yield is 1.24% at the current price. It paid out 40% of its profit as dividend in FY26.

Is CHEMCRUX ENTERPRISES LTD. debt-free?

No. It reported borrowings of ₹34 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹31 Cr after cash. Debt stands at 0.44× equity. That is higher than 76% of its 99 Specialty Chemicals peers.

Is CHEMCRUX ENTERPRISES LTD. expensive compared with its peers?

On trailing P/E, CHEMCRUX ENTERPRISES LTD. ranks 66 of 99 in Specialty Chemicals — cheaper than 34% of them, against an industry median of 23.1×. This is a position, not a valuation judgement.

When are CHEMCRUX ENTERPRISES LTD.'s next results?

Financial Results on Mon, 2 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track CHEMCRUX ENTERPRISES LTD.'s announcements?

Every NSE and BSE filing by CHEMCRUX ENTERPRISES LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.